Rockwell Medical Inc (RMTI)
1.50
+0.05
(+3.45%)
USD |
NASDAQ |
Apr 22, 16:00
1.52
+0.02
(+1.33%)
Pre-Market: 20:00
Rockwell Medical Total Return Level: 1.50 for April 22, 2024
Total Return Level Chart
Historical Total Return Level Data
Date | Value |
---|---|
April 22, 2024 | 1.50 |
April 19, 2024 | 1.45 |
April 18, 2024 | 1.48 |
April 17, 2024 | 1.48 |
April 16, 2024 | 1.49 |
April 15, 2024 | 1.525 |
April 12, 2024 | 1.60 |
April 11, 2024 | 1.62 |
April 10, 2024 | 1.58 |
April 09, 2024 | 1.62 |
April 08, 2024 | 1.62 |
April 05, 2024 | 1.65 |
April 04, 2024 | 1.69 |
April 03, 2024 | 1.63 |
April 02, 2024 | 1.66 |
April 01, 2024 | 1.70 |
March 28, 2024 | 1.66 |
March 27, 2024 | 1.64 |
March 26, 2024 | 1.65 |
March 25, 2024 | 1.62 |
March 22, 2024 | 1.71 |
March 21, 2024 | 1.52 |
March 20, 2024 | 1.65 |
March 19, 2024 | 1.41 |
March 18, 2024 | 1.39 |
Date | Value |
---|---|
March 15, 2024 | 1.40 |
March 14, 2024 | 1.39 |
March 13, 2024 | 1.46 |
March 12, 2024 | 1.44 |
March 11, 2024 | 1.54 |
March 08, 2024 | 1.52 |
March 07, 2024 | 1.53 |
March 06, 2024 | 1.50 |
March 05, 2024 | 1.48 |
March 04, 2024 | 1.47 |
March 01, 2024 | 1.56 |
February 29, 2024 | 1.41 |
February 28, 2024 | 1.36 |
February 27, 2024 | 1.37 |
February 26, 2024 | 1.37 |
February 23, 2024 | 1.26 |
February 22, 2024 | 1.29 |
February 21, 2024 | 1.33 |
February 20, 2024 | 1.34 |
February 16, 2024 | 1.35 |
February 15, 2024 | 1.39 |
February 14, 2024 | 1.29 |
February 13, 2024 | 1.29 |
February 12, 2024 | 1.34 |
February 09, 2024 | 1.30 |
Total Return Level Definition
The total return level allows investors to view the performance of a security inclusive of both price appreciation and dividends/distributions. Total return level is seen as the most accurate calculation that produces returns consistent with most other sources.
Total Return Level Range, Past 5 Years
0.8426
Minimum
Nov 09 2022
62.70
Maximum
May 08 2019
11.67
Average
6.186
Median
Oct 20 2021
Total Return Level Benchmarks
Cyclacel Pharmaceuticals Inc | 1.75 |
Oragenics Inc | 1.06 |
Alpine Immune Sciences Inc | 64.58 |
Corvus Pharmaceuticals Inc | 1.44 |
MAIA Biotechnology Inc | 2.26 |